Drug Database
Back to search

Netherlands· NL-a6a72ab1917c

Flammazine, crème 1%

A silver sulfadiazine product containing zilversulfadiazine, registered in Netherlands by Essential Pharmaceuticals Limited. The same ATC class is registered in 7 of our 19 countries.

ATC D06BA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFlammazine, crème 1%ATCD06BA01REGISTER NO.NL-a6a72ab1917cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zilversulfadiazineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Silver sulfadiazine is registered in 7 of 19 countries.

Countries holding a registration under ATC D06BA01 (silver sulfadiazine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search silver sulfadiazine products by name

Silver sulfadiazine · ATC D06BA01

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZILVERSULFADIAZINE
Manufacturer
Essential Pharmaceuticals Limited
Country
Netherlands (NL)
ATC code
D06BA01
ATC class
Silver sulfadiazine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    06705

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

23 interactions on record for silver sulfadiazine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check silver sulfadiazine against other medicinesHow interaction checks work

Silver sulfadiazine · interactions on record

23 records

  • 1 severe
  • 22 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • LidocaineC05AD01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Silver sulfadiazine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silver sulfadiazine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Flammazine
  • Belgium · Flammazine
  • Bulgaria · Дермазин
  • Cyprus · Silvederma, Sylfio
  • Germany · Flammazine
  • Estonia · Sulfargin
  • Spain · Flammazine, Silvederma
  • France · Flammazine
  • United Kingdom (Northern Ireland) · Flamazine
  • Greece · Sylfio
  • Croatia · Dermazin
  • Hungary · Dermazin
  • Italy · Sofargen
  • Lithuania · Sulfargin
  • Luxembourg · Flammazine
  • Latvia · Sulfargin
  • Malta · Silvederma
  • Portugal · Flammazine
  • Romania · Dermazin, Regen-Ag
  • Slovenia · Dermazin
  • Slovakia · Dermazin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf2f9850-cfc2-4a81-b969-6abc41a281b0
GET /v1/drugs/bf2f9850-cfc2-4a81-b969-6abc41a281b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h06705_smpc.pdf",
  "strength": null,
  "atc_label": "Silver Sulfadiazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg06705",
  "excipients": [
    "CETYLALCOHOL",
    "GLYCEROLMONOSTEARAAT 40-55 (E 471)",
    "PARAFFINE, VLOEIBAAR (E905)",
    "POLYSORBAAT 60 (E 435)",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "ZILVERSULFADIAZINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h06705.pdf",
  "authorised_at": "1973/11/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "06705",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about silver sulfadiazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console